Evidence map›Paper›PMID 33300885›Full record

ArticleJMIR research protocols2020

A Culturally Adapted SMS Text Messaging Intervention to Promote Antiretroviral Therapy Adherence Among African Americans: Protocol for a Single-Arm Trial.

Maulika Kohli, Elizabeth C Pasipanodya, Jessica L Montoya, Maria Marquine, Martin Hoenigl, Vanessa Serrano, Clint Cushman, Rogelio Garcia, John Kua, Verna Gant and 2 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.0field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Maulika KohliHIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0001-7572-9697
Elizabeth C PasipanodyaRehabilitation Research Center, Santa Clara Valley Medical Center, San Jose, CA, United States.ORCID https://orcid.org/0000-0001-8142-9498
Jessica L MontoyaHIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0002-0318-7590
Maria MarquineHIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0003-2249-6628
Martin HoeniglUniversity of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0002-1653-2824
Vanessa SerranoHIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0003-1575-7666
Clint CushmanHIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0001-5851-5312
Rogelio GarciaFamily Health Centers of San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0001-7139-712X
John KuaFamily Health Centers of San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0002-3944-8537
Verna GantFamily Health Centers of San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0002-3081-1969
Sarah RojasSan Diego State University, San Diego, CA, United States.ORCID https://orcid.org/0000-0003-0268-1682
David J MooreHIV Neurobehavioral Research Program, University of California San Diego, San Diego, CA, United States.ORCID https://orcid.org/0000-0001-9699-318X
University of California San Diego · USFamily Health Centers of San Diego · USSan Diego State University · USSanta Clara Valley Medical Center · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
Alcohol Research in the Science/Practitioner ModelT32AA013525 · NIAAA · SAN DIEGO STATE UNIVERSITY · PI EDWARD P RILEY, ANDREA SPADONI TOWNSEND · 2002 to 2026
$8.4M
NIAAA NIH HHS T32 AA013525NIMH NIH HHS P30 MH062512
6 · The paper itself

Abstract

backgroundAfrican Americans are disproportionally affected by HIV and have poorer rates of antiretroviral therapy (ART) adherence compared to other racial or ethnic groups in the United States. Factors associated with poor HIV disease outcomes are commonly associated with sociostructural barriers that prevent engagement with and retention in HIV care. SMS text messaging interventions to promote ART adherence among predominantly non-Hispanic White persons with HIV (PWH) have been shown to be efficacious; however, limited research has been devoted to culturally tailoring interventions for underrepresented racial/ethnic groups. Considering African Americans show poorer engagement along the HIV care continuum, we developed an individualized and culturally tailored two-way SMS text messaging intervention to improve ART adherence and associated virologic suppression among African American PWH.

objectiveIn this paper we describe the protocol of a culturally tailored individualized Texting for Adherence Building (iTAB) intervention in a 24- to 48-week, single-arm study.

methodsWe developed a culturally tailored iTAB intervention, which we are implementing in a 24- to 48-week, single-arm study. Participants were recruited from the Family Health Centers of San Diego (FHCSD), a federally qualified health center. Patient inclusion criteria were (1) receiving care at the FHCSD, (2) living with HIV, (3) self-identification as Black, African American, or of African ancestry, (4) English speaking, (5) age 18 or older, (6) currently on ART, and (7) able to provide informed consent. Study enrollment began in November 2017 and closed in July 2019. A total of 90 participants from the FHCSD enrolled in the iTAB intervention, and we anticipate completing data collection in July 2020. Participants were assisted in individualizing and customizing their SMS text message preferences at the baseline study visit. Self-assessment measures are collected at baseline, interim, and final study visits. Problems related to sending/receiving SMS text messages and barriers to ART adherence are assessed at each interim study visit. The FHCSD staff monitors and tracks participants' daily SMS text message responses to ART adherence reminders using a clinical dashboard.

resultsWe hypothesize that the proportion of individuals achieving HIV virologic suppression (viral load <40 copies/mL) will be greater at the end of the intervention period compared to the proportion prior to study implementation. Additionally, we anticipate that rates of virologic suppression at the end of the intervention among participants receiving iTAB will be comparable to those among the general FHCSD non-African American population who did not receive iTAB. Finally, we anticipate a high response rate to iTAB SMS text messages as well as positive participant feedback at the end of the intervention with regard to the acceptability of, satisfaction with, and perceived efficacy of iTAB.

conclusionsThe iTAB intervention is a novel individualized two-way SMS text messaging intervention that has been culturally tailored for use among African Americans with HIV. We anticipate that iTAB will demonstrate efficacy in future randomized control trials and will be supportive of medication adherence among other populations facing health disparities. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/21592.

Indexed as

behavior modificationHIV/AIDSmedication adherencemHealthshort message service

Identifiers

PMID33300885
PMCPMC7759437
OpenAlexW3089037838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.